Literature DB >> 16269553

Parental consent for newborn screening in southern Taiwan.

M-C Huang1, C-K Lee, S-J Lin, I-C Lu.   

Abstract

OBJECTS: With the advent of genetic technologies, many genetic/metabolic disorders can be detected asymptomatically but might be untreatable, and the benefits and risks of screening for them are not fully known. The purpose of this study is to explore current practice with regard to the parental consent process in newborn screening (NBS).
DESIGN: Staff in 23 obstetric clinics/hospitals that conduct NBS in one city of southern Taiwan were interviewed. Using content analysis, 15 interview transcripts, eight completed questionnaires, and other relevant documents from the 23 clinics/hospitals were analysed to reveal the framework of the parental consent process in NBS in southern Taiwan. MAIN MEASURES: Three categories-informed consent, informed dissent, and no informed/consent-were developed to analyse the parental consent process in NBS.
RESULTS: The parental consent procedures in NBS and the quality of the information provided before obtaining consent vary widely. Because the traditional NBS was incorporated into routine paediatric practices in most clinics/hospitals, the most frequently encountered consent model is "informed dissent" (60.9%) and "no informed/consent" (30.4%); while an "informed consent" model (45.5%) is the frequent model for screening rare metabolic/genetic disorders.
CONCLUSIONS: Specific guidelines to regulate the parental consent process for NBS are essential. Further studies should investigate parental responses to NBS, taking these as the basis on which to establish an informed consent model in Taiwan.

Entities:  

Keywords:  Empirical Approach; Genetics and Reproduction; Health Care and Public Health

Mesh:

Year:  2005        PMID: 16269553      PMCID: PMC1734047          DOI: 10.1136/jme.2004.010074

Source DB:  PubMed          Journal:  J Med Ethics        ISSN: 0306-6800            Impact factor:   2.903


  6 in total

1.  Newborn screening: should explicit parental consent be required?

Authors:  Mei-Chih Huang; Shio-Jean Lin
Journal:  Acta Paediatr Taiwan       Date:  2003 May-Jun

2.  Genetic and metabolic screening of newborns: must health care providers seek explicit parental consent?

Authors:  S Wildeman; J Downie
Journal:  Health Law J       Date:  2001

Review 3.  Ethical issues in genetics.

Authors:  N Fost
Journal:  Pediatr Clin North Am       Date:  1992-02       Impact factor: 3.278

Review 4.  Some ethical and design challenges of screening programs and screening tests.

Authors:  Matthew J McQueen
Journal:  Clin Chim Acta       Date:  2002-01       Impact factor: 3.786

5.  Genetic screening and ethics: European perspectives.

Authors:  R Chadwick; H ten Have; J Husted; M Levitt; T McGleenan; D Shickle; U Wiesing
Journal:  J Med Philos       Date:  1998-06

Review 6.  Newborn screening and genetic testing.

Authors:  Michele A Lloyd-Puryear; Irene Forsman
Journal:  J Obstet Gynecol Neonatal Nurs       Date:  2002 Mar-Apr
  6 in total
  3 in total

1.  Stakeholder attitudes towards the role and application of informed consent for newborn bloodspot screening: a study protocol.

Authors:  S G Nicholls; L Tessier; H Etchegary; J C Brehaut; B K Potter; R Z Hayeems; P Chakraborty; J Marcadier; J Milburn; D Pullman; L Turner; B J Wilson
Journal:  BMJ Open       Date:  2014-11-24       Impact factor: 2.692

2.  A policy analysis of the national phenylketonuria screening program in Iran.

Authors:  Alireza Heidari; Mohammad Arab; Behzad Damari
Journal:  BMC Health Serv Res       Date:  2021-02-05       Impact factor: 2.655

3.  Challenges of Implementation of the National Phenylketonuria Screening Program in Iran: A Qualitative Study.

Authors:  Alireza Heidari; Mohammad Arab; Koorosh Etemad; Behzad Damari; Mohammad Javad Kabir
Journal:  Electron Physician       Date:  2016-10-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.